ESC 365 - Is the subxiphoidal pacemaker with an epicardial lead a safe therapy for pacemaker dependent patients after device explantation due to infection?

EHRA Premium Access

Is the subxiphoidal pacemaker with an epicardial lead a safe therapy for pacemaker dependent patients after device explantation due to infection?

Session: Poster session 3 - Complications in device therapy

Topic: Antibradycardia pacing

Speaker: Doctor S. Fehrendt (Bernau bei Berlin, DE)

Event: EHRA 2018

Congress Presentation

Add to my library

About the speaker

Doctor Stefanie Fehrendt

Brandenburg Heart Centre, Bernau bei Berlin (Germany)

0 follower

9 more presentations in this session

Individual discriminators contribution to the reduction of inappropriate therapies in implantable defibrillators.

Speaker: Doctor C. Gunturiz Beltran (Castellon, ES)

Different scenarios leading to inappropriate therapy inhibition in single chamber ICD detection programming

Speaker: Professor J. De Pooter (Gent, BE)

Pacemaker implantation in iatrogenic bradycardia: clinical, analytical and electrical predictors of heart rhythm disturbances persistence

Speaker: Doctor L. Marques (Sra. da Hora, PT)

Battery malfunction of a leadless cardiac pacemaker

Speaker: Professor S. Richter (Dresden, DE)

Different pacemaker and ICD lead models may be associated with different incidences of mechanical complications

Speaker: Ms I. Serbanescu (Constanta, RO)

Access the full session

Poster session 3 - Complications in device therapy

Speakers: Doctor S. Fehrendt, Doctor C. Gunturiz Beltran, Professor J. De Pooter, Doctor L. Marques, Professor S. Richter...

About the event

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources